Biocon Biologics gets U.S. FDA approval for biosimilar aflibercept Yesafili, enters US ophthalmology market
Biocon Biologics gets U.S. FDA approval for biosimilar aflibercept …
May 20, 2024
theprint.in
Biocon Biologics eyes $7 billion global opportunity with new biosimilar approvals - CNBC TV18
Biocon Biologics eyes $7 billion global opportunity with new biosi…
8 months ago
cnbctv18.com
Biocon eyes in-licensing to boost biosimilars portfolio, targets margin expansion
Biocon eyes in-licensing to boost biosimilars portfolio, targets marg…
2 weeks ago
rediff.com
Yesafili : procédure d'injection intravitréenne
13:28
Yesafili : procédure d'injection intravitréenne
48 views1 month ago
DailymotionANSM
Biocon’s Global Biosimilars Portfolio - Insulin Glargine
Biocon’s Global Biosimilars Portfolio - Insulin Glargine
Aug 30, 2022
biocon.com
Biocon Merges Generics and Biosimilars, Names Stanford PhD as Successor | Salil Kallianpur posted on the topic | LinkedIn
Biocon Merges Generics and Biosimilars, Names Stanford PhD …
18.4K views3 weeks ago
linkedin.com
Biocon share price hits lifetime high on USFDA approval to cancer drug; stock jumps 6%
Biocon share price hits lifetime high on USFDA approval to cancer dru…
Jun 4, 2018
zeebiz.com
Biocon Limited acquired Biosimilars Newco Limited.
Jul 19, 2023
marketscreener.com
1:06
Biocon Biologics completes $3 bn acquisition of biosimilar, biz Viatri…
523 viewsNov 30, 2022
FacebookCNBC-TV18
3:33
Biocon Biologics sees strong FY27 as new biosimilars gain traction - …
3 months ago
cnbctv18.com
Biocon Biologics expects FY27 growth from new approvals, weigh…
3 months ago
cnbctv18.com
5:40
Tariff policy steers clear of generics & biosimilars to keep healthcare a…
6 months ago
MSNCNBC
Biocon to Evaluate Merger with Subsidiary Biologics
May 12, 2025
marketscreener.com
Biocon Biologics may reveal details of its likely IPO post integration o…
Sep 7, 2023
cnbctv18.com
Biocon | LinkedIn
10 months ago
linkedin.com
Biocon may list biosimilars business by 2025 first half - CEO
Aug 11, 2023
theprint.in
Biocon Biologics CEO Discusses Merger and IPO Plans
6 months ago
marketscreener.com
2:07
Biocon Biologics is well-placed to take advantage of opportunities i…
Aug 14, 2023
CNBC
Biocon Success Story - How Kiran Shaw made it a Billion Dollar Com…
Sep 29, 2022
startuptalky.com
Biocon partners SII to make vaccine, drug manufacturing accessible to …
Sep 17, 2021
theprint.in
Biocon, le géant indien qui surfe sur la vague des biosimilaires
9 months ago
lesechos.fr
3:17
Biocon: There's a myth that cutting prices is unprofitable
Oct 15, 2019
CNBC
Biocon Biologics joins Novartis, Pfizer to distribute cancer drugs i…
Mar 9, 2021
theprint.in
Biocon Biologics CEO terms Eris Lifesciences deal as enabling, not …
Mar 15, 2024
cnbctv18.com
11:42
Biocon Looks To Margin Expansion Ahead
3 months ago
MSNBT TV
Biocon raises Rs 2,250 crore from selling 10% stake in Syngene to fu…
Feb 10, 2023
cnbctv18.com
1:38
Biocon Biologics Secures Global Settlement for Yesafili Launch; Bi…
163 views5 months ago
YouTubeNiftyBN - Nifty BN Channel
2:02
Biocon Biologics Secures Health Canada Approval for Yesafili™, a…
220 views11 months ago
YouTubeNiftyBN - Nifty BN Channel
1:02
Biocon Biologics: Revolutionizing Healthcare with Biosimilars
282 viewsMay 2, 2023
YouTubeBiocon Biologics
1:42
Innovator Biologics vs. Biosimilars vs. Interchangeables
14.1K viewsJul 14, 2022
YouTubeAlliance for Patient Access
See more videos
Static thumbnail place holder